These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 24178744)

  • 1. Synthesis and biological evaluation of glucagon-like peptide-1 receptor agonists.
    Zhang YJ; Shen LL; Cheon HG; Xu YN; Jeong JH
    Arch Pharm Res; 2014 May; 37(5):588-99. PubMed ID: 24178744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two small molecule agonists of glucagon-like peptide-1 receptor modulate the receptor activation response differently.
    Cheong YH; Kim MK; Son MH; Kaang BK
    Biochem Biophys Res Commun; 2012 Jan; 417(1):558-63. PubMed ID: 22177947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel approach to exploit Small-Molecule glucagon-like Peptide-1 receptor agonists with high potency.
    Wang X; Yun Y; Chen L; Guo S; Niu B; Fang J; Yuan Q; Shen J; Xie X; Wang K
    Bioorg Med Chem; 2024 Jun; 107():117761. PubMed ID: 38795571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of conformationally constrained glucagon-like peptide-1 derivatives with increased plasma stability and prolonged in vivo activity.
    Miranda LP; Winters KA; Gegg CV; Patel A; Aral J; Long J; Zhang J; Diamond S; Guido M; Stanislaus S; Ma M; Li H; Rose MJ; Poppe L; Véniant MM
    J Med Chem; 2008 May; 51(9):2758-65. PubMed ID: 18412318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vitro biological evaluation of new pyrimidines as glucagon-like peptide-1 receptor agonists.
    AlNeyadi SS; Adem A; Amer N; Salem AA; Abdou IM
    Bioorg Med Chem Lett; 2017 Nov; 27(22):5071-5075. PubMed ID: 28988756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential impact of amino acid substitutions on critical residues of the human glucagon-like peptide-1 receptor involved in peptide activity and small-molecule allostery.
    Koole C; Wootten D; Simms J; Miller LJ; Christopoulos A; Sexton PM
    J Pharmacol Exp Ther; 2015 Apr; 353(1):52-63. PubMed ID: 25630467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eleven amino acid glucagon-like peptide-1 receptor agonists with antidiabetic activity.
    Mapelli C; Natarajan SI; Meyer JP; Bastos MM; Bernatowicz MS; Lee VG; Pluscec J; Riexinger DJ; Sieber-McMaster ES; Constantine KL; Smith-Monroy CA; Golla R; Ma Z; Longhi DA; Shi D; Xin L; Taylor JR; Koplowitz B; Chi CL; Khanna A; Robinson GW; Seethala R; Antal-Zimanyi IA; Stoffel RH; Han S; Whaley JM; Huang CS; Krupinski J; Ewing WR
    J Med Chem; 2009 Dec; 52(23):7788-99. PubMed ID: 19702274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of a glucagon-like peptide 1-albumin conjugate: the ability to activate the glucagon-like peptide 1 receptor in vivo.
    Kim JG; Baggio LL; Bridon DP; Castaigne JP; Robitaille MF; Jetté L; Benquet C; Drucker DJ
    Diabetes; 2003 Mar; 52(3):751-9. PubMed ID: 12606517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.
    Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K
    Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The major determinant of exendin-4/glucagon-like peptide 1 differential affinity at the rat glucagon-like peptide 1 receptor N-terminal domain is a hydrogen bond from SER-32 of exendin-4.
    Mann RJ; Nasr NE; Sinfield JK; Paci E; Donnelly D
    Br J Pharmacol; 2010 Aug; 160(8):1973-84. PubMed ID: 20649595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A β-peptide agonist of the GLP-1 receptor, a class B GPCR.
    Denton EV; Craig CJ; Pongratz RL; Appelbaum JS; Doerner AE; Narayanan A; Shulman GI; Cline GW; Schepartz A
    Org Lett; 2013 Oct; 15(20):5318-21. PubMed ID: 24087900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying glucagon-like peptide-1 mimetics using a novel functional reporter gene high-throughput screening assay.
    Chen J; Bai G; Yang Y; Geng P; Cao Y; Zhu Y
    Peptides; 2007 Apr; 28(4):928-34. PubMed ID: 17267075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclobutane derivatives as novel nonpeptidic small molecule agonists of glucagon-like peptide-1 receptor.
    Liu Q; Li N; Yuan Y; Lu H; Wu X; Zhou C; He M; Su H; Zhang M; Wang J; Wang B; Wang Y; Ma D; Ye Y; Weiss HC; Gesing ER; Liao J; Wang MW
    J Med Chem; 2012 Jan; 55(1):250-67. PubMed ID: 22103243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and Evaluation of 3-Phenyloxetane Derivative Agonists of the Glucagon-Like Peptide-1 Receptor.
    Zhang Z; Pan H; Guo L; Cai C; Chen T; Zhang Z; Yang X; Zheng H; Jiang C; Wang Z; Yang Y; Wang Z; Zhang X; Zhang Y; Liu D
    J Med Chem; 2024 Sep; 67(17):14820-14839. PubMed ID: 39140772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding sites and design strategies for small molecule GLP-1R agonists.
    Zhang H; Wu T; Wu Y; Peng Y; Wei X; Lu T; Jiao Y
    Eur J Med Chem; 2024 Sep; 275():116632. PubMed ID: 38959726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel peptidic dual GLP-1/glucagon receptor agonist alleviates diabetes and diabetic complications in combination with low-intensity ultrasound.
    Ding WX; Wang HY; Peng LJ; Zhang F; Yuan S; Zhao LH
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12423-12436. PubMed ID: 33336763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide-1 receptor dimerization differentially regulates agonist signaling but does not affect small molecule allostery.
    Harikumar KG; Wootten D; Pinon DI; Koole C; Ball AM; Furness SG; Graham B; Dong M; Christopoulos A; Miller LJ; Sexton PM
    Proc Natl Acad Sci U S A; 2012 Nov; 109(45):18607-12. PubMed ID: 23091034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-molecule agonists for the glucagon-like peptide 1 receptor.
    Knudsen LB; Kiel D; Teng M; Behrens C; Bhumralkar D; Kodra JT; Holst JJ; Jeppesen CB; Johnson MD; de Jong JC; Jorgensen AS; Kercher T; Kostrowicki J; Madsen P; Olesen PH; Petersen JS; Poulsen F; Sidelmann UG; Sturis J; Truesdale L; May J; Lau J
    Proc Natl Acad Sci U S A; 2007 Jan; 104(3):937-42. PubMed ID: 17213325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecule allosteric modulation of the glucagon-like Peptide-1 receptor enhances the insulinotropic effect of oxyntomodulin.
    Willard FS; Wootten D; Showalter AD; Savage EE; Ficorilli J; Farb TB; Bokvist K; Alsina-Fernandez J; Furness SG; Christopoulos A; Sexton PM; Sloop KW
    Mol Pharmacol; 2012 Dec; 82(6):1066-73. PubMed ID: 22930710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of structure-activity relationships at the two C-terminal residues of potent 11mer Glucagon-Like Peptide-1 receptor agonist peptides via parallel synthesis.
    Haque TS; Martinez RL; Lee VG; Riexinger DG; Lei M; Feng M; Koplowitz B; Mapelli C; Cooper CB; Zhang G; Huang C; Ewing WR; Krupinski J
    Peptides; 2010 Jul; 31(7):1353-60. PubMed ID: 20420872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.